New hope for pancreatic cancer: two drug cocktails face off
NCT ID NCT05026905
First seen Jan 24, 2026 · Last updated May 24, 2026 · Updated 15 times
Summary
This study compares two experimental drug combinations for people with metastatic pancreatic cancer that has spread. The goal is to see which combo works better at shrinking tumors and delaying cancer growth. About 66 adults who have not had chemotherapy for their advanced cancer are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHASE II, OPEN-LABEL, PARALLEL 2-ARM, MULTI-CENTER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
China Medical University Hospital
Taichung, 400, Taiwan
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, 800, Taiwan
-
National Cheng Kung University Hospital
Tainan, 600, Taiwan
-
Taichung Veterans General Hospital
Taichung, Taiwan
Conditions
Explore the condition pages connected to this study.